Ex­clu­sive: Saris­sa's board push drew lit­tle sup­port in Alk­er­mes share­hold­er vote

Saris­sa Cap­i­tal Man­age­ment lost its proxy bat­tle bad­ly against Irish drug­mak­er Alk­er­mes last week, ac­cord­ing to a fi­nal tal­ly of votes for board nom­i­nees. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER